Literature DB >> 12588790

Physical exercise increases urinary excretion of lipoxin A4 and related compounds.

Sebastiano Gangemi1, Graziella Luciotti, Etrusca D'Urbano, Agostino Mallamace, Domenico Santoro, Guido Bellinghieri, Giovanni Davi, Mario Romano.   

Abstract

Lipoxins (LX) are lipoxygenase-derived eicosanoids with potent anti-inflammatory activities and vascular bed-dependent vasodilatory actions. LX can be formed in vitro and in vivo in a number of conditions, and we have reported that immunoreactive LXA(4) (iLXA(4)) is physiologically excreted with human urine. Using a recently developed LX extraction method coupled to an ELISA, we examined whether iLXA(4) excretion was modified by strenuous exercise, which is known to trigger potential LX-forming events. Maximal exertion significantly increased iLXA(4) urinary excretion in nine healthy volunteers (0.061 +/- 0.023 vs. 0.113 +/- 0.057 ng/mg creatinine; P = 0.028). iLXA(4) levels returned to baseline after 6 h and increased, although at a smaller extent, after 24 h. A significant correlation (r = 0.988) was denoted between iLXA(4) ELISA measurements and reversed-phase high-performance liquid chromatography quantitation of a previously described urinary tetraene, confirming its LXA(4)-related nature. These findings show for the first time that an increase in excretion of LXA(4)-related compounds can be observed in response to strenuous exercise. This may be the reflection of an enhanced LX biosynthesis, which may represent a safeguard mechanism that keeps the inflammatory reaction triggered by physical stress under control.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12588790     DOI: 10.1152/japplphysiol.01004.2002

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  19 in total

1.  Renin-angiotensin-aldosterone system in insulin resistance and metabolic syndrome.

Authors:  Undurti N Das
Journal:  J Transl Int Med       Date:  2016-07-07

Review 2.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 3.  Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.

Authors:  Gabrielle Fredman; Ira Tabas
Journal:  Am J Pathol       Date:  2017-06       Impact factor: 4.307

4.  A defect in the activities of Δ and Δ desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease.

Authors:  Undurti N Das
Journal:  World J Diabetes       Date:  2011-11-15

Review 5.  A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution.

Authors:  Charles N Serhan
Journal:  Histochem Cell Biol       Date:  2004-08-21       Impact factor: 4.304

6.  Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.

Authors:  Nan Chiang; Edmund A Bermudez; Paul M Ridker; Shelley Hurwitz; Charles N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-07       Impact factor: 11.205

7.  Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment.

Authors:  James F Markworth; Luke Vella; Benjamin S Lingard; Dedreia L Tull; Thusitha W Rupasinghe; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-10-02       Impact factor: 3.619

8.  Exercise Promotes Resolution of Acute Inflammation by Catecholamine-Mediated Stimulation of Resolvin D1 Biosynthesis.

Authors:  Jing-Juan Zheng; Ernesto Pena Calderin; Bradford G Hill; Aruni Bhatnagar; Jason Hellmann
Journal:  J Immunol       Date:  2019-10-25       Impact factor: 5.422

9.  Lipoxins as biomarkers of lupus and other inflammatory conditions.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2011-05-15       Impact factor: 3.876

10.  Metabolipidomic profiling reveals an age-related deficiency of skeletal muscle pro-resolving mediators that contributes to maladaptive tissue remodeling.

Authors:  James F Markworth; Lemuel A Brown; Eunice Lim; Jesus A Castor-Macias; Jacqueline Larouche; Peter C D Macpherson; Carol Davis; Carlos A Aguilar; Krishna Rao Maddipati; Susan V Brooks
Journal:  Aging Cell       Date:  2021-06-02       Impact factor: 11.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.